SMi's 3rd annual Antibody Drug Conjugates Summit comes at the perfect time to focus on innovative manufacturing techniques, preclinical and clinical data and next generation ADCs, bringing together key industry experts from academia, pharma and biotech companies.Join us and hear case studies, presentations and round tables demonstrating how to maximise the therapeutic index of your ADC and how this form of empowered antibody is transforming ne...

The 11th High Content Analysis conference, featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments. SELECTBIO is pleased to present the 11th High Content Analysis conference, which will take place at the Fira Barcelona, on May 14th and 15th 2014. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developme...

The European Conference on Rare Diseases and Orphan Products (ECRD) is the unique platform/forum across all rare diseases, across all European countries, bringing together all stakeholders: patients’ representatives, academics, health care professionals, industry, payers, regulators and policy makers. ECRD covers research, development of new treatments, healthcare, social care, information, public health and support at European, national...

The conference will allow you to Understand cross border regulatory requirements, the impact of the pending EU regulations, consent, efficient storage and tracking strategies to ensure quality will allow you to move forward with your research and improve your drug discovery process.We bring together leaders from industry, academia and institutions from across the globe facilitating learning and development to maximise your research opportuniti...

Join us at this year's Medical Device & Manufacturing Texas event to enhance your knowledge and understanding of the latest MedTech industry innovations and emerging technologies.The Nation's Most Trusted Resource for Medical Device Design & Manufacturing Returns to Texas! -Enhance your knowledge and understanding of the latest industry innovations and emerging technologies -Benefit from live presentations from leading industry experts...

The World Heart Federation looks forward to welcoming you to Melbourne, Australia for the World Congress of Cardiology 2014 (WCC 2014) taking place from 4-7 May 2014: A global platform for cardiovascular disease specialists and public health professionals to share knowledge and network with their peers World leading experts presenting 150 sessions on cardiology, policy and public healthLatest scientific findings featured in over 1,000 new abs...

Cphi's Design of Experiments workshop is a 2 Day programme and will provide practical Doe knowledge suitable for those involved in carrying out experiments while undertaking Api r&d, improving processIt is 2 day hands on workshop for Api r&d and quality professionals from pharmaceutical and Api manufacturing companies on implementation of Doe. The speakers would be international Doe experts who will be leading a practical workshop for...

The Geneva Health Forum is not just another conference on health. By looking to the future, it brings vision and thrives on all participants unique experiences and in depth insights on topics and initiatives generated and implemented all over the world. Pooling intelligence will bring value and challenge common ideas to explore new territories of freethinking and build on inter-sectoral approaches to solving the problems of our time.

The latest legislation waives the obligation to submit PSURs routinely for generic products, well-established use products, homoeopathic products, and traditional herbal products. The submission frequency will be variable and risk based. For these, PSURs shall be submitted where there is a condition in the MA or when requested by a Competent Authority on the basis of concerns relating to pharmacovigilance data or due to the absence of PSURs fo...

Antibiotic resistance in bacteria poses a major problem to modern public health. Infections that were once routinely treated with antibiotics have become extremely problematic to effectively kill, making even simple surgical operations dangerous from the perspective of contracting a resistant infection . Resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus, have sprung up in hospitals where they must be carefully...